Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2000
05/30/2000CA2119128C Alleviation of symptoms associated with inflammatory disease states
05/26/2000CA2252967A1 Protein fragments for use in protein targeting
05/25/2000WO2000029626A1 Rhadino virus lana acts in trans on a unit of rhadino virus dna to mediate efficient episome persistence
05/25/2000WO2000029603A2 Low cost manufacture of oligosaccharides
05/25/2000WO2000029602A1 Transfection of male germ cells for generation of selectable transgenic stem cells
05/25/2000WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species
05/25/2000WO2000029599A1 Viral vectors with late transgene expression
05/25/2000WO2000029594A1 Root-specific promoter
05/25/2000WO2000029586A2 Maize dna ligase i orthologue and uses thereof
05/25/2000WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029581A1 Human tslp dna and polypeptides
05/25/2000WO2000029580A1 Calcium binding protein
05/25/2000WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029566A1 Promoters for gene expression in the roots of plants
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000WO2000029558A1 UDP-GALACTOSE: β-$I(N)-ACETYL-GLUCOSAMINE β1,3GALACTOSYLTRANSFERASES, β3GAL-T5
05/25/2000WO2000029557A1 A sensitive screening system for envelope-defective recombinant virus
05/25/2000WO2000029554A2 Compositions for preserving haptenized tumor cells for use in vaccines
05/25/2000WO2000029553A1 Bioengineered tissue constructs and methods for producing and using them
05/25/2000WO2000029552A1 Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
05/25/2000WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy
05/25/2000WO2000029550A2 Low oxygen culturing of central nervous system progenitor cells
05/25/2000WO2000029549A2 Low oxygen culturing of cells
05/25/2000WO2000029548A2 Coupled peptides
05/25/2000WO2000029447A1 Rhamm antagonist antibodies
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same
05/25/2000WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029432A1 Heliobacter pylori antigen
05/25/2000WO2000029430A1 Ring finger protein zapop3
05/25/2000WO2000029423A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029020A1 Anti-icam-r antibody-induced apoptosis
05/25/2000WO2000029012A2 Methods of alleviating cancer symptoms
05/25/2000WO2000029002A2 In utero transplantation of human mesenchymal stem cells
05/25/2000WO2000028813A1 Treatment of myelogenous leukemia
05/25/2000WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
05/25/2000WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
05/25/2000WO2000015816A3 Maize replication protein a
05/25/2000WO2000015788A3 Dna sequence encoding oncofetal ferritin protein
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000014205A3 Methods for generating high titer helper-free preparations of released recombinant aav vectors
05/25/2000WO2000008924A9 Method of performing transgenesis
05/25/2000WO2000008443A9 Multiple frequency fluorescence lifetime imaging
05/25/2000WO2000008194A3 Cell lines for the propagation of mutated herpes viruses
05/25/2000WO2000007545A8 Apoptosis proteins
05/25/2000WO2000004051A3 Growth differentiation factor promoter and uses therefor
05/25/2000WO2000001801A9 Ftsz multimeric proteins and their uses
05/25/2000WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000CA2779042A1 Bioengineered tissue constructs and methods for producing and using them
05/25/2000CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000CA2351874A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000CA2351551A1 Low oxygen culturing of cells
05/25/2000CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351313A1 Immunoglobulin superfamily proteins
05/25/2000CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same
05/25/2000CA2351022A1 Low cost manufacture of oligosaccharides
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350603A1 Ring finger protein zapop3
05/25/2000CA2350415A1 Inflammation-associated genes
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2350389A1 Calcium binding protein
05/25/2000CA2350186A1 Promoters for gene expression in the roots of plants
05/25/2000CA2350124A1 A sensitive screening system for envelope-defective recombinant virus
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000CA2350079A1 Udp-galactose: beta-n-acetyl-glucosamine beta1,3galactosyltransferases. beta3gal-t5
05/25/2000CA2349762A1 Human tslp dna and polypeptides
05/25/2000CA2349581A1 Anti-icam-r antibody-induced apoptosis
05/25/2000CA2348825A1 Maize dna ligase i orthologue and uses thereof
05/25/2000CA2348824A1 12 human secreted proteins
05/25/2000CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000CA2345934A1 Coupled peptides
05/25/2000CA2317723A1 Root-specific promoter
05/24/2000EP1002870A1 Androgen- and progesteron-receptor binding Hormone Response Element
05/24/2000EP1002869A1 A chemically synthesised artificial promotor for high level expression of transgenes and a method for its synthesis
05/24/2000EP1002867A1 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
05/24/2000EP1002864A1 HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
05/24/2000EP1002862A1 Methods of diagnosing or treating neurological diseases
05/24/2000EP1002859A1 Seeding of cells
05/24/2000EP1002538A2 Stem cell and lymphocyte storage
05/24/2000EP1002132A1 90 human secreted proteins
05/24/2000EP1002120A1 Chimeric adenoviral vectors
05/24/2000EP1002118A1 Processes for increasing the yield in plants
05/24/2000EP1002116A2 Stress tolerance and delayed senescence in plants
05/24/2000EP1002115A1 Universal chloroplast integration and expression vectors, transformed plants and products thereof
05/24/2000EP1002114A1 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants
05/24/2000EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
05/24/2000EP1002106A1 Production and use of recombinant protein multimers with altered biological activity
05/24/2000EP1002104A1 Novel metalloprotease
05/24/2000EP1002099A1 Synaptojanin isoform
1 ... 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 ... 1827